Stellate Therapeutics Overview
- Year Founded
-
2009
- Status
-
Out of Business
- Employees
-
10
- Latest Deal Type
-
Out of Business
- Financing Rounds
-
10
Stellate Therapeutics General Information
Description
Developer of microbiome-derived molecules intended to fight age-related neurological diseases. The company focuses on performing comprehensive research on gut-brain axis pathologies and developing the drug candidate, a potential first-in-class therapy for Parkinson's disease, thereby enabling access to an effective cure.
Contact Information
Website
www.stellate-tx.comCorporate Office
- 47 Rue de Montmorency
- 75003 Paris
- France
Corporate Office
- 47 Rue de Montmorency
- 75003 Paris
- France
Stellate Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Stellate Therapeutics Signals
Stellate Therapeutics FAQs
-
When was Stellate Therapeutics founded?
Stellate Therapeutics was founded in 2009.
-
Where is Stellate Therapeutics headquartered?
Stellate Therapeutics is headquartered in Paris, France.
-
What is the size of Stellate Therapeutics?
Stellate Therapeutics has 10 total employees.
-
What industry is Stellate Therapeutics in?
Stellate Therapeutics’s primary industry is Drug Discovery.
-
Is Stellate Therapeutics a private or public company?
Stellate Therapeutics is a Private company.
-
What is Stellate Therapeutics’s current revenue?
The current revenue for Stellate Therapeutics is .
-
How much funding has Stellate Therapeutics raised over time?
Stellate Therapeutics has raised $12M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process